How Does the Fundamental Picture Look for CVS Health Corporation (CVS)?

CVS Health Corporation (NYSE:CVS) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 69.21B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. As the day-to-day narrative ebbs and flows for this company, it is more important than ever to step back and get a bird’s eye view of the fundamental reality under the surface of this story.

CVS Health Corporation (NYSE:CVS) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CVS, the company currently has 1.7 billion of cash on the books, which is offset by 4.82 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 95.13 billion in total assets, balanced by 57.44 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

CVS Health Corporation (CVS) saw -642 million in free cash flow last quarter, representing a quarterly net change in cash of -789 million. Perhaps most importantly where cash movements are concerned, the company saw about -136 million in net operating cash flow.

CVS Health Corporation (NYSE:CVS) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 48.39 billion in total revenues. That represents a quarterly year/year change in revenues of 0.05 in sequential terms, the CVS saw sales decline by 0.05.

But what about the bottom line? After all, that’s what really matters in the end. CVS Health Corporation (CVS) is intriguing when broken down to its core data. The cost of selling goods last quarter was 40.49 billion, yielding a gross basic income of 7.9 billion. For shareholders, given the total diluted outstanding shares of 1.02 billion, this means overall earnings per share of 3.22. Note, this compares with a consensus analyst forecast of 1.4 in earnings per share for its next fiscal quarterly report.

Is CVS Health Corporation (NYSE:CVS) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 6.74 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 9.92. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on CVS Health Corporation.

Previous ArticleNext Article

Related Post

Babcock & Wilcox Enterprises, Inc. (BW): Chec... It is interesting to note that Babcock & Wilcox Enterprises, Inc. (NYSE:BW) is active and made a solid movement in the last trading day. Now tradi...
Energy Transfer Equity, L.P. (ETE) Key Indicators ... Energy Transfer Equity, L.P. (NYSE:ETE) gained 3.81% in Tuesday’s session, going up from its prior closing price of $17.06 to $17.71, and has now reco...
New York REIT, Inc. (NYRT) vs. Alexandria Real Est... New York REIT, Inc. (NYSE:NYRT) and Alexandria Real Estate Equities, Inc. (NYSE:ARE) are the two most active stocks in the REIT - Office industry base...
The Fundamental Case for and Against Occidental Pe... Occidental Petroleum Corporation (NYSE:OXY) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a...
Drilling Down Into the Books for Helios and Mathes... It's worth it to have a look at Helios and Matheson Analytics Inc. (NASDAQ:HMNY) as there may be a chasm between the bulls and the bears as far as rec...